Literature DB >> 8921430

Differential production of IL-12 in BALB/c and DBA/2 mice controls IL-4 versus IFN-gamma synthesis in primed CD4 lymphocytes.

R S Gieni1, Y Fang, G Trinchieri, D T Umetsu, R H DeKruyff.   

Abstract

The profile of cytokines produced by CD4 T cells is profoundly influenced by the presence of IL-12. Here we demonstrate that during re-stimulation of antigen-specific immune responses in vitro, antigen-primed lymph node cells from DBA/2 mice produced 3- to 30-fold more IL-12 than did cells from BALB/c mice, which are identical at the major histocompatibility locus. The strain differences in IL-12 production were observed only in antigen-driven responses (and not in responses induced by bacterial products), and were dependent upon an interaction between CD4 T cells and lymph node adherent cells. In addition, differences in the quantity of IL-12 produced by DBA/2 and BALB/c antigen-presenting cells (APC) was not dependent on differential production of IFN-gamma by T cells, since APC from DBA/2 mice still produced much greater quantities of IL-12 than did BALB/c APC when each was cultured with the same H-2d-restricted Th2 clones, in the complete absence of IFN-gamma, or when each was cultured with primed (BALB/c x DBA/2)F1 T cells. The level of IL-12 produced in the cultures critically affected cytokine production in CD4 T cells, since neutralization of endogenous IL-12 in DBA/2 cultures, which are predisposed towards developing Th1 responses, reduced IFN-gamma production and enhanced IL-4 synthesis to levels normally seen in BALB/c cultures, which are predisposed toward developing Th2 responses. We propose therefore that differential production of antigen-driven IL-12 is a mechanism by which the genetic background in DBA/2 and BALB/c mice can affect the pattern of cytokine synthesis by T cells during the development of adaptive immune responses.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8921430     DOI: 10.1093/intimm/8.10.1511

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  7 in total

1.  An antibody specific for interleukin-6 reverses age-associated changes in spontaneous and induced cytokine production in mice.

Authors:  R M Gorczynski; B Cinader; V Ramakrishna; E Terzioglu; T Waelli; O Westphal
Journal:  Immunology       Date:  1997-09       Impact factor: 7.397

2.  Age-dependent rise in IFN-γ competence undermines effective type 2 responses to nematode infection.

Authors:  Bhavya Kapse; Hongwei Zhang; Nicole Affinass; Friederike Ebner; Susanne Hartmann; Sebastian Rausch
Journal:  Mucosal Immunol       Date:  2022-06-11       Impact factor: 7.313

3.  Evaluation of bioadhesive capacity and immunoadjuvant properties of vitamin B(12)-Gantrez nanoparticles.

Authors:  Hesham H Salman; Carlos Gamazo; P Chris de Smidt; Gregory Russell-Jones; Juan M Irache
Journal:  Pharm Res       Date:  2008-08-05       Impact factor: 4.200

4.  Molecular markers of susceptibility to ocular toxoplasmosis, host and guest behaving badly.

Authors:  Adriana Lima Vallochi; Anna Carla Goldberg; Angela Falcai; Rajendranath Ramasawmy; Jorge Kalil; Cláudio Silveira; Rubens Belfort; Luiz Vicente Rizzo
Journal:  Clin Ophthalmol       Date:  2008-12

Review 5.  TIM-1, a novel allergy and asthma susceptibility gene.

Authors:  Jennifer J McIntire; Dale T Umetsu; Rosemarie H DeKruyff
Journal:  Springer Semin Immunopathol       Date:  2003-10-24

6.  Development of a Bacillus subtilis-based rotavirus vaccine.

Authors:  Sangun Lee; Boris R Belitsky; James P Brinker; Kathryn O Kerstein; David W Brown; John D Clements; Gerald T Keusch; Saul Tzipori; Abraham L Sonenshein; John E Herrmann
Journal:  Clin Vaccine Immunol       Date:  2010-09-01

7.  Genetic regulation of commitment to interleukin 4 production by a CD4(+) T cell-intrinsic mechanism.

Authors:  M Bix; Z E Wang; B Thiel; N J Schork; R M Locksley
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.